Sébastien Lalanne

5PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Jun 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study.

Sébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet

|Aug 09, 2024
Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.

Florian Lemaitre, Sébastien Lalanne, Marie-Clémence Verdier

|Feb 27, 2020
Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).

Sébastien Lalanne, Marc Le Vée, Florian Lemaitre

Pageof 1

Frequent Collaborators

5 joint publications

Florian Lemaitre

2 joint publications

Nadège Néant

2 joint publications

Minh P Lê

2 joint publications

Stéphane Bouchet